Vatilen®
Warning: Undefined variable $x in /www/aspen-lab.com/htdocs/wp-content/themes/labtechco-child/functions.php on line 120
Palbociclib
Therapeutic action
Cyclin-dependent kinase inhibitor.
Indications
HR-positive, HER2-negative advanced or metastatic breast cancer.
Presentation
21 hard capsules of 75 mg, 100 mg. or 125 mg.